Synairgen plc SNG.L Stock
6.3 GBP
{{ price }}
-12.499995%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United Kingdom
Exchange
LSE
Market Cap
12.69M GBP
LOW - HIGH [24H]
0.0000
-
0.0000 GBP
VOLUME [24H]
108.33K GBP
{{ volume }}
P/E Ratio
0
Earnings per share
-0.05 GBP
Synairgen plc Price Chart
Synairgen plc SNG.L Financial and Trading Overview
| Synairgen plc stock price | 6.3 GBP |
| Previous Close | 7.94 GBP |
| Open | 0 GBP |
| Bid | 7.51 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 36.48 GBP |
| Volume | 182 GBP |
| Avg. Volume | 603.33K GBP |
| Market Cap | 15.1M GBP |
| Beta (5Y Monthly) | -2.208045 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40 GBP |
SNG.L Valuation Measures
| Enterprise Value | -3686827 GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.025167786 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 74.25742 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.183 |
Trading Information
Synairgen plc Stock Price History
| Beta (5Y Monthly) | -2.208045 |
| 52-Week Change | -73.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 36.48 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 9.74 GBP |
| 200-Day Moving Average | 14.31 GBP |
SNG.L Share Statistics
| Avg. Volume (3 month) | 603.33K GBP |
| Avg. Daily Volume (10-Days) | 385.51K GBP |
| Shares Outstanding | 201.38M |
| Float | 139.22M |
| Short Ratio | N/A |
| % Held by Insiders | 3.34% |
| % Held by Institutions | 30.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.22% |
| Return on Equity (ttm) | -61.61% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -20198000 GBP |
| Net Income Avi to Common (ttm) | -17645000 GBP |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.68M GBP |
| Total Cash Per Share (mrq) | 0.1 GBP |
| Total Debt (mrq) | 0 GBP |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.191 |
| Book Value Per Share (mrq) | 0.101 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14286000 GBP |
| Levered Free Cash Flow (ttm) | -9194500 GBP |
Profile of Synairgen plc
| Country | United Kingdom |
| State | N/A |
| City | Southampton |
| Address | Mailpoint 810 |
| ZIP | SO16 6YD |
| Phone | 44 23 8051 2800 |
| Website | https://www.synairgen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Q&A For Synairgen plc Stock
What is a current SNG.L stock price?
Synairgen plc SNG.L stock price today per share is 6.3 GBP.
How to purchase Synairgen plc stock?
You can buy SNG.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Synairgen plc?
The stock symbol or ticker of Synairgen plc is SNG.L.
Which industry does the Synairgen plc company belong to?
The Synairgen plc industry is Biotechnology.
How many shares does Synairgen plc have in circulation?
The max supply of Synairgen plc shares is 2.01M.
What is Synairgen plc Price to Earnings Ratio (PE Ratio)?
Synairgen plc PE Ratio is now.
What was Synairgen plc earnings per share over the trailing 12 months (TTM)?
Synairgen plc EPS is -0.05 GBP over the trailing 12 months.
Which sector does the Synairgen plc company belong to?
The Synairgen plc sector is Healthcare.
Synairgen plc SNG.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}